FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda has given "May Apply" recommendation to Nirman Agri Genetics IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 1 | 0 | 0 | 0 |
% | 0.00 | 100.00 | 0.00 | 0.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Dilip Davda | May Apply |
[Dilip Davda] NAGL is in the business of hybrid seeds manufacturing and marketing along with related bio-organic products. Based on its FY23 super earnings, the issue appears fully priced. Dilution of over 34% equity raise concern. Well-informed investors may consider an investment with a long-term perspective. Read detail review...
Nirman Agri Genetics IPO Reviews, analysis and views by popular members. Read Nirman Agri Genetics Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 1 | 0 | 0 | 0 |
% | 100.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
RajaBanks |
Apply for Short Term at Cut-off Price 1. Agri Genetics is a growing industry which will be needed in the future due to various reasons like overpopulation, soil fertility issues etc... |
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|